Plus Therapeutics to Present ReSPECT Phase 1 Dose Escalation Study Results for Leptomeningeal Metastases at the 2025 San Antonio Breast Cancer Symposium (GlobeNewswire) - Dec 1, 2025 - "Study findings to be featured in a poster spotlight presentation."
P1 data • Brain Cancer • CNS Tumor
|